Bibliografía

Bibliografía básica
 

  • BAÑOS DÍEZ JE, FARRE ALBALADEJO M. Principios de Farmacología Clínica. Bases científicas de la utilización de medicamentos, ISBN 84-458-1166-5. Editorial Masson. 2002.
  •  

  • FLOREZ J. Farmacología Humana. ISBN 84-458-1290-4. Editorial Masson. 4ª edición 2005
  •  

  • IRWIN RS, RIPPE JM. Intensive Care Medicine. Lippincott Willians and Wilki. 7ª edition. 2011. ISBN-13:978-1608311835. Section 10: Pharmacology (Chapters 117-120).
  •  

  • VARON J, ACOSTA P. Handbook of Critical and Intensive Care Medicine. ISBN  978-0-387-92850-0 (Chapter 19: Pharmacology agents commonly used in the intensive care) Springer Sicience. 2th edition. 2010.
  •  

  • HAGIHARA A, HASEGAWA M, ABE T, NAGATA T, WAKATA Y, MIYAZAKI S. Prehospital epinephrine use and survival among patients with out-of-hospital cardiac arrest. JAMA. 2012 Mar 21;307 (11):1161-8. doi: 10.1001/jama.2012.294
  •  

  •  CALLAWAY CW. Questioning the use of epinephrine to treat cardiac arrest. JAMA. 2012 Mar 21;307(11):1198-200. doi: 10.1001/jama.2012.313
  •  

  •  LARABEE TM, LIU KY, CAMPBELL JA, LITTLE CM. Vasopressors in cardiac arrest: a systematic review. Resuscitation. 2012 Aug;83(8):932-9. doi: 10.1016/j.resuscitation.2012.02.029. Epub 2012 Mar 15.
  •  

  •  SOAR J, NOLAN JP, BÖTTIGER BW, PERKINS GD, LOTT C, CARLI P ET AL. Adult advanced life support section Collaborators. European Resuscitation Council Guidelines for Resuscitation 2015: Section 3. Adult advanced life support. Resuscitation. 2015 Sep 17. pii: S0300-9572(15)00328-7. doi: 10.1016/j.resuscitation.2015.07.016. [Epub ahead of print]
  •  

  • ANGUS DC, VAN DER POLL T. Severe sepsis and septic shock. N Engl J Med 2013; 369(9): 840-51.
  •  

  • ROBERTS JA, LIPMAN J. Dose Adjustment and Pharmacokinetics of Antibiotics in Severe Sepsis and Septic Shock. En: Rello J, Kollef M, Díaz E, Rodiríguez A, editores. Infectious Diseases in Critical Care. Berlín:  Springer; 2007. pp 122-146
  •  

  • SCHMIDT GA, MANDEL J. Evaluation and management of severe sepsis and septic shock in adults.  En: UpToDate, Finlay G (Ed), UpToDate, Waltham, MA, 2015.

 

Bibliografía complementaria
 

  • OPAL SM, LATERRE P-F, FARNCOIS B, ET AL. Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis. The ACCESS Randomized Trial. JAMA 2013; 309(11): 1154-1162.
  •  

  • ALEJANDRIA MM, LANSANG MA, DANS LF, MANTARING JB 3rd. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev 2013; 9:CD001090.
  •  

  • CRUZ DN, ANTONELLI M, FUMAGALLI R, ET AL. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009; 301: 2445-2452.
  •  

  • LIVIGNI S, BERTOLINI G, ROSSI C, ET AL. Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: A multicenter randomised controlled clinical trial. BMJ Open 2014; 4: e003536.
  •  

  • MEISEL C, SCHEFOLD JC, PSCHOWSKI R, ET AL. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 2009; 180: 640-648.
  •  

  • JOANNES-BOYAU O, HONORE PM, PEREZ P, ET AL. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 2013; 39: 1535-1546.
  •  

  • WANG C, CHI C, GUO L, ET AL. Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis. Critical Care 2014, 18:563 doi:10.1186/s13054-014-0563-4
  •  

  • STAUBACH KH, SCHRÖDER J, STÜBER F, ET AL. Effect of pentoxifylline in severe sepsis: results of a randomized, double-blind, placebo-controlled study. Arch Surg 1998; 133:94.
  •  

  • KRUGER PS, HARWARD ML, JONES MA, ET AL. Continuation of Statin Therapy in Patients with Presumed Infection A Randomized Controlled Trial. Am J Respir Crit Care Med 2011; 183: 774-781.
  •  

  • MORELLI A, ERTMER C, WESTPHAL M, ET AL. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 2013; 310:1683.

 
 

Jueves, 18 de febrero de 2016